Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers.
Benjamin GarmezyJinesh S GheeyaHeather Y LinYuefan HuangTaebeom KimXian-Li JiangKyaw Zin TheinPatrick G PiliéFadl ZeineddineWanlin WangKenna Rael ShawJordi Rodon AhnertJohn Paul ShenYing YuanFunda Meric-BernstamKen ChenTimothy A YapPublished in: JCO precision oncology (2022)
mutation as a predictive biomarker of ICI therapy.
Keyphrases